RxDoctor Payments DataLook up a doctor →

Donald Anderson

Psychiatry · Banning, CANPI 1447362082

Payments from drug & device makers

$10,513,866in general payments, 2019–2025

Across 843 payments — averaging $12,472 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$2.9M
  • Sage Therapeutics, LLC$1.5M
  • Biogen$1.2M
  • Axsome Therapeutics, Inc.$1M
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$756K
  • AbbVie$726K
  • plus $2.5M from 14 others
$33,482in research payments, 2019–2025

Across 15 payments — averaging $2232.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$32K
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$1K

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$10,513,866 in reported general payments places this provider in the 95th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California

Other psychiatry in Banning

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →